In a filing, Bio-Techne Corp revealed its Officer JOSHUA MOLHO acquired Company’s shares for reported $63705.0 on Jun 09 ’25. In the deal valued at $49.77 per share,1,280 shares were bought.
Then, Herr Amy E. sold 1,860 shares, generating $122,691 in total proceeds. Upon selling the shares at $65.96, the Director now owns 1,976 shares.
Before that, JOSHUA MOLHO bought 1,860 shares. Bio-Techne Corp shares valued at $122,691 were divested by the Domestic Partner of Director at a price of $65.96 per share.
Wells Fargo initiated its Bio-Techne Corp [TECH] rating to an Overweight in a research note published on May 30, 2025; the price target was $59. A number of analysts have revised their coverage, including KeyBanc Capital Markets’s analysts, who decreased its forecast for the stock in early April from “an Overweight” to “a Sector weight”. Evercore ISI began covering TECH with “an Outperform” recommendation on March 18, 2025. Robert W. Baird revised its rating on February 19, 2025. It rated TECH as “a Neutral” which previously was an “an Outperform”.
Price Performance Review of TECH
On Tuesday, Bio-Techne Corp [NASDAQ:TECH] saw its stock jump 3.05% to $51.40. Over the last five days, the stock has gained 5.37%. Bio-Techne Corp shares have fallen nearly -28.64% since the year began. Nevertheless, the stocks have fallen -34.80% over the past one year.
How much short interest is there in Bio-Techne Corp?
A steep rise in short interest was recorded in Bio-Techne Corp stocks on 2025-05-15, growing by 0.75 million shares to a total of 7.2 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 6.46 million shares. There was a rise of 10.36%, which implies that there is a positive sentiment for the stock.
